BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Rühl J, Leung CS, Münz C. Vaccination against the Epstein-Barr virus. Cell Mol Life Sci 2020;77:4315-24. [PMID: 32367191 DOI: 10.1007/s00018-020-03538-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Enokida T, Moreira A, Bhardwaj N. Vaccines for immunoprevention of cancer. J Clin Invest 2021;131:146956. [PMID: 33938446 DOI: 10.1172/JCI146956] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Läderach F, Münz C. Epstein Barr Virus Exploits Genetic Susceptibility to Increase Multiple Sclerosis Risk. Microorganisms 2021;9:2191. [PMID: 34835317 DOI: 10.3390/microorganisms9112191] [Reference Citation Analysis]
3 Granato M. Nanotechnology Frontiers in γ-Herpesviruses Treatments. Int J Mol Sci 2021;22:11407. [PMID: 34768838 DOI: 10.3390/ijms222111407] [Reference Citation Analysis]
4 Münz C. The Role of Lytic Infection for Lymphomagenesis of Human γ-Herpesviruses. Front Cell Infect Microbiol 2021;11:605258. [PMID: 33842383 DOI: 10.3389/fcimb.2021.605258] [Reference Citation Analysis]
5 Häfner SJ. This is not a pipe - But how harmful is electronic cigarette smoke. Biomed J 2021;44:227-34. [PMID: 34091092 DOI: 10.1016/j.bj.2021.05.006] [Reference Citation Analysis]
6 Kobayashi H, Seki R, Ujita M, Hirayama K, Yamada S, Ohashi R, Otsuki Y, Watanabe T, Yoshino T. An Autopsy Case of an Elderly Patient with Classic Hodgkin Lymphoma Presenting with a Plethora of Clinical Symptoms and Signs. Am J Case Rep 2020;21:e926177. [PMID: 33087692 DOI: 10.12659/AJCR.926177] [Reference Citation Analysis]
7 Münz C. Probing Reconstituted Human Immune Systems in Mice With Oncogenic γ-Herpesvirus Infections. Front Immunol 2020;11:581419. [PMID: 33013936 DOI: 10.3389/fimmu.2020.581419] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 van Gisbergen KPJM, Zens KD, Münz C. T-cell memory in tissues. Eur J Immunol 2021;51:1310-24. [PMID: 33837521 DOI: 10.1002/eji.202049062] [Reference Citation Analysis]
9 Jean-Pierre V, Lupo J, Buisson M, Morand P, Germi R. Main Targets of Interest for the Development of a Prophylactic or Therapeutic Epstein-Barr Virus Vaccine. Front Microbiol 2021;12:701611. [PMID: 34239514 DOI: 10.3389/fmicb.2021.701611] [Reference Citation Analysis]
10 Cai J, Zhang B, Li Y, Zhu W, Akihisa T, Li W, Kikuchi T, Liu W, Feng F, Zhang J. Prophylactic and Therapeutic EBV Vaccines: Major Scientific Obstacles, Historical Progress, and Future Direction. Vaccines (Basel) 2021;9:1290. [PMID: 34835222 DOI: 10.3390/vaccines9111290] [Reference Citation Analysis]
11 Bayó C, Jung G, Español-Rego M, Balaguer F, Benitez-Ribas D. Vaccines for Non-Viral Cancer Prevention. Int J Mol Sci 2021;22:10900. [PMID: 34681560 DOI: 10.3390/ijms222010900] [Reference Citation Analysis]
12 Zhao X, Pan X, Wang Y, Zhang Y. Targeting neoantigens for cancer immunotherapy. Biomark Res 2021;9:61. [PMID: 34321091 DOI: 10.1186/s40364-021-00315-7] [Reference Citation Analysis]
13 Jakhmola S, Hazarika Z, Jha AN, Jha HC. In silico analysis of antiviral phytochemicals efficacy against Epstein-Barr virus glycoprotein H. J Biomol Struct Dyn 2021;:1-14. [PMID: 33438528 DOI: 10.1080/07391102.2020.1871074] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]